Crossmark Global Holdings’s Medidata Solutions, Inc. MDSO Stock Holding History

Crossmark Global Holdings’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,350	Closed	-$490K	–	1469
2019 Q3	$490K	Buy	5,350 +50	+0.9%	+$4.57K	0.01%	787
2019 Q2	$480K	Sell	5,300 -390	-7%	-$34.2K	0.01%	835
2019 Q1	$417K	Buy	5,690 +80	+1%	+$5.77K	0.01%	925
2018 Q4	$378K	Sell	5,610 -4,300	-43%	-$303K	0.01%	915
2018 Q3	$727K	Sell	9,910 -300	-3%	-$24K	0.02%	734
2018 Q2	$823K	Buy	10,210 +470	+5%	+$35.2K	0.02%	685
2018 Q1	$612K	Sell	9,740 -170	-2%	-$11.3K	0.02%	807
2017 Q4	$628K	Buy	9,910 +2,300	+30%	+$164K	0.02%	839
2017 Q3	$594K	Buy	+7,610	New	+$579K	0.02%	855
2016 Q3	$594K	Buy	+7,610	New	+$403K	0.02%	855

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Crossmark Global Holdings's MDSO Position: Q4 2019 in Review

Crossmark Global Holdings sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 5,350 shares — an estimated $490K sold.

Crossmark Global Holdings first reported a position in MDSO in Q3 2016 and held it in 10 quarters. The position peaked at $823K in Q2 2018. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

Crossmark Global Holdings reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
Crossmark Global Holdings sold 5,350 Medidata Solutions, Inc. shares in Q4 2019, an estimated $490K.
Crossmark Global Holdings first reported a position in Medidata Solutions, Inc. in Q3 2016 and held it in 10 quarters.
Crossmark Global Holdings's Medidata Solutions, Inc. position peaked at $823K in Q2 2018.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Crossmark Global Holdings's 13F filing for Q4 2019, filed 6 Feb 2020.